메뉴 건너뛰기




Volumn 25, Issue 11, 2014, Pages 2167-2172

One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group

(16)  Tandstad, T a   Stahl O b   Hakansson U b   Dahl, O c,d   Haugnes, H S e,f   Klepp, O H g   Langberg, C W h   Laurell, A i   Oldenburg, J h   Solberg, A a   Soderstrom K j   Cavallin Stah E k   Stierner, U k   Wahlquist, R h   Wall, N l   Cohn Cedermark, G m,n  


Author keywords

Adjuvant chemotherapy; Nonseminoma; Testicular cancer

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; ANTINEOPLASTIC AGENT;

EID: 84918827743     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu375     Document Type: Article
Times cited : (112)

References (27)
  • 1
    • 84984868774 scopus 로고    scopus 로고
    • Regionalt cancercentrum Stockholm/Gotland og Syd
    • Nationell rapport för Testikkelcancerregistret. Seminom och Non-seminom 2012: Regionalt cancercentrum Stockholm/Gotland og Syd 2013.
    • (2013) Seminom och Non-seminom 2012
  • 2
    • 34247374725 scopus 로고    scopus 로고
    • Controversies in the management of clinical stage I testis cancer
    • de Wit R, Fizazi K. Controversies in the management of clinical stage I testis cancer. J Clin Oncol 2006; 24: 5482-5492.
    • (2006) J Clin Oncol , vol.24 , pp. 5482-5492
    • de Wit, R.1    Fizazi, K.2
  • 3
    • 0038222521 scopus 로고    scopus 로고
    • Surveillance in stage I testicular cancer
    • discussion 83-75
    • Daugaard G, Petersen PM, Rorth M. Surveillance in stage I testicular cancer. APMIS 2003; 111: 76-83; discussion 83-75.
    • (2003) APMIS , vol.111 , pp. 76-83
    • Daugaard, G.1    Petersen, P.M.2    Rorth, M.3
  • 4
    • 77950592867 scopus 로고    scopus 로고
    • Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy
    • Kollmannsberger C, Moore C, Chi KN et al. Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy. Ann Oncol 2010; 21: 1296-1301.
    • (2010) Ann Oncol , vol.21 , pp. 1296-1301
    • Kollmannsberger, C.1    Moore, C.2    Chi, K.N.3
  • 5
    • 79952280455 scopus 로고    scopus 로고
    • Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's Experience
    • Sturgeon JF, Moore MJ, Kakiashvili DM et al. Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's Experience. Eur Urol 2011; 59: 556-562.
    • (2011) Eur Urol , vol.59 , pp. 556-562
    • Sturgeon, J.F.1    Moore, M.J.2    Kakiashvili, D.M.3
  • 6
    • 0029866244 scopus 로고    scopus 로고
    • Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report
    • Cullen MH, Stenning SP, Parkinson MC et al. Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report. J Clin Oncol 1996; 14: 1106-1113.
    • (1996) J Clin Oncol , vol.14 , pp. 1106-1113
    • Cullen, M.H.1    Stenning, S.P.2    Parkinson, M.C.3
  • 7
    • 65549112965 scopus 로고    scopus 로고
    • Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program
    • Tandstad T, Dahl O, Cohn-Cedermark G et al. Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program. J Clin Oncol 2009; 27: 2122-2128.
    • (2009) J Clin Oncol , vol.27 , pp. 2122-2128
    • Tandstad, T.1    Dahl, O.2    Cohn-Cedermark, G.3
  • 8
    • 84866775094 scopus 로고    scopus 로고
    • Surveillance or adjuvant treatments in stage 1 testis germ-cell tumours
    • Cullen M. Surveillance or adjuvant treatments in stage 1 testis germ-cell tumours. Ann Oncol 2012; 23(Suppl 10): x342-x348.
    • (2012) Ann Oncol , vol.23 , pp. x342-x348
    • Cullen, M.1
  • 9
    • 0344604538 scopus 로고    scopus 로고
    • Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors
    • Bohlen D, Borner M, Sonntag RW et al. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors. J Urol 1999; 161: 1148-1152.
    • (1999) J Urol , vol.161 , pp. 1148-1152
    • Bohlen, D.1    Borner, M.2    Sonntag, R.W.3
  • 10
    • 46449084133 scopus 로고    scopus 로고
    • Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I nonseminomatous testicular germ cell tumors: AUO Trial AH 01/94 by the German Testicular Cancer Study Group
    • Albers P, Siener R, Krege S et al. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I nonseminomatous testicular germ cell tumors: AUO Trial AH 01/94 by the German Testicular Cancer Study Group. J Clin Oncol 2008; 26: 2966-2972.
    • (2008) J Clin Oncol , vol.26 , pp. 2966-2972
    • Albers, P.1    Siener, R.2    Krege, S.3
  • 11
    • 65549088972 scopus 로고    scopus 로고
    • Vox populi: using community-based studies to determine best management of early-stage nonseminoma
    • Nichols CR, Kollmannsberger C. Vox populi: using community-based studies to determine best management of early-stage nonseminoma. J Clin Oncol 2009; 27: 2114-2116.
    • (2009) J Clin Oncol , vol.27 , pp. 2114-2116
    • Nichols, C.R.1    Kollmannsberger, C.2
  • 12
    • 84875591927 scopus 로고    scopus 로고
    • Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
    • Beyer J, Albers P, Altena R et al. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol 2013; 24: 878-888.
    • (2013) Ann Oncol , vol.24 , pp. 878-888
    • Beyer, J.1    Albers, P.2    Altena, R.3
  • 13
    • 79959546636 scopus 로고    scopus 로고
    • EAU guidelines on testicular cancer: 2011 update
    • Albers P, Albrecht W, Algaba F et al. EAU guidelines on testicular cancer: 2011 update. Eur Urol 2011; 60: 304-319.
    • (2011) Eur Urol , vol.60 , pp. 304-319
    • Albers, P.1    Albrecht, W.2    Algaba, F.3
  • 14
    • 77951177381 scopus 로고    scopus 로고
    • Canadian consensus guidelines for the management of testicular germ cell cancer
    • Wood L, Kollmannsberger C, Jewett M et al. Canadian consensus guidelines for the management of testicular germ cell cancer. Can Urol Assoc J 2010; 4: e19-e38.
    • (2010) Can Urol Assoc J , vol.4 , pp. e19-e38
    • Wood, L.1    Kollmannsberger, C.2    Jewett, M.3
  • 15
    • 77956104590 scopus 로고    scopus 로고
    • Long-term follow-up after riskadapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study
    • Tandstad T, Cohn-Cedermark G, Dahl O et al. Long-term follow-up after riskadapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study. Ann Oncol 2010; 21: 1858-1863.
    • (2010) Ann Oncol , vol.21 , pp. 1858-1863
    • Tandstad, T.1    Cohn-Cedermark, G.2    Dahl, O.3
  • 16
    • 79956308293 scopus 로고    scopus 로고
    • Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group
    • Olofsson SE, Tandstad T, Jerkeman M et al. Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group. J Clin Oncol 2011; 29: 2032-2039.
    • (2011) J Clin Oncol , vol.29 , pp. 2032-2039
    • Olofsson, S.E.1    Tandstad, T.2    Jerkeman, M.3
  • 17
    • 0031037241 scopus 로고    scopus 로고
    • International Germ Cell Cancer Collaborative Group
    • International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997; 15: 594-603.
    • (1997) J Clin Oncol , vol.15 , pp. 594-603
  • 18
    • 36749062011 scopus 로고    scopus 로고
    • Long-term follow-up results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis
    • Westermann DH, Schefer H, Thalmann GN et al. Long-term follow-up results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis. J Urol 2008; 179: 163-166.
    • (2008) J Urol , vol.179 , pp. 163-166
    • Westermann, D.H.1    Schefer, H.2    Thalmann, G.N.3
  • 19
    • 33745075685 scopus 로고    scopus 로고
    • Treating stage I nonseminomatous germ cell tumours with a single cycle of chemotherapy
    • Gilbert DC, Norman AR, Nicholl J et al. Treating stage I nonseminomatous germ cell tumours with a single cycle of chemotherapy. BJU Int 2006; 98: 67-69.
    • (2006) BJU Int , vol.98 , pp. 67-69
    • Gilbert, D.C.1    Norman, A.R.2    Nicholl, J.3
  • 20
    • 84869231872 scopus 로고    scopus 로고
    • Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up
    • Haugnes HS, Bosl GJ, Boer H et al. Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up. J Clin Oncol 2012; 30: 3752-3763.
    • (2012) J Clin Oncol , vol.30 , pp. 3752-3763
    • Haugnes, H.S.1    Bosl, G.J.2    Boer, H.3
  • 21
    • 77952881067 scopus 로고    scopus 로고
    • Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy
    • Brydoy M, Fossa SD, Klepp O et al. Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy. Eur Urol 2010; 58: 134-140.
    • (2010) Eur Urol , vol.58 , pp. 134-140
    • Brydoy, M.1    Fossa, S.D.2    Klepp, O.3
  • 22
    • 65549149701 scopus 로고    scopus 로고
    • Long-term cognitive function among testicular cancer survivors treated with chemotherapy
    • Skoogh J, Steineck G, Stierner U et al. Long-term cognitive function among testicular cancer survivors treated with chemotherapy. J Clin Oncol 2008; 26 (suppl); abstr 5035.
    • (2008) J Clin Oncol , vol.26
    • Skoogh, J.1    Steineck, G.2    Stierner, U.3
  • 23
    • 70449358522 scopus 로고    scopus 로고
    • Sperm DNA integrity in cancer patients: the effect of disease and treatment
    • Stahl O, Eberhard J, Cavallin-Stahl E et al. Sperm DNA integrity in cancer patients: the effect of disease and treatment. Int J Androl 2009; 32: 695-703.
    • (2009) Int J Androl , vol.32 , pp. 695-703
    • Stahl, O.1    Eberhard, J.2    Cavallin-Stahl, E.3
  • 24
    • 27944437869 scopus 로고    scopus 로고
    • Paternity following treatment for testicular cancer
    • Brydoy M, Fossa SD, Klepp O et al. Paternity following treatment for testicular cancer. J Natl Cancer Inst 2005; 97: 1580-1588.
    • (2005) J Natl Cancer Inst , vol.97 , pp. 1580-1588
    • Brydoy, M.1    Fossa, S.D.2    Klepp, O.3
  • 25
    • 67649965345 scopus 로고    scopus 로고
    • Pulmonary function in long-term survivors of testicular cancer
    • Haugnes HS, Aass N, Fossa SD et al. Pulmonary function in long-term survivors of testicular cancer. J Clin Oncol 2009; 27: 2779-2786.
    • (2009) J Clin Oncol , vol.27 , pp. 2779-2786
    • Haugnes, H.S.1    Aass, N.2    Fossa, S.D.3
  • 26
    • 33847330070 scopus 로고    scopus 로고
    • Components of the metabolic syndrome in long-term survivors of testicular cancer
    • Haugnes HS, Aass N, Fossa SD et al. Components of the metabolic syndrome in long-term survivors of testicular cancer. Ann Oncol 2007; 18: 241-248.
    • (2007) Ann Oncol , vol.18 , pp. 241-248
    • Haugnes, H.S.1    Aass, N.2    Fossa, S.D.3
  • 27
    • 84891506358 scopus 로고    scopus 로고
    • Active surveillance is the preferred approach to clinical stage I testicular cancer
    • Nichols CR, Roth B, Albers P et al. Active surveillance is the preferred approach to clinical stage I testicular cancer. J Clin Oncol 2013; 31: 3490-3493.
    • (2013) J Clin Oncol , vol.31 , pp. 3490-3493
    • Nichols, C.R.1    Roth, B.2    Albers, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.